Cart
sales@molnova.com
Alalevonadifloxacin
CAS No. 2892364-59-7
Alalevonadifloxacin( —— )
Catalog No. M36008 CAS No. 2892364-59-7
Alalevonadifloxacin is a DNA gyrase and DNA topoisomerase inhibitor and a novel antibacterial compound of the quinolone class targeting MRSa.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 257 | In Stock |
|
| 5MG | 207 | In Stock |
|
| 10MG | 300 | In Stock |
|
| 25MG | 463 | In Stock |
|
| 50MG | 613 | In Stock |
|
| 100MG | 827 | In Stock |
|
| 200MG | 1097 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlalevonadifloxacin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlalevonadifloxacin is a DNA gyrase and DNA topoisomerase inhibitor and a novel antibacterial compound of the quinolone class targeting MRSa.
-
DescriptionAlalevonadifloxacin is a DNA gyrase and DNA topoisomerase inhibitor and a novel antibacterial compound of the quinolone class targeting MRSa. Alalevonadifloxacin is potentially useful in the treatment of bacterial Gram-positive, Gram-negative and anaerobic infections.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetTopoisomerase
-
RecptorTopoisomerase | DNA gyrase | Antibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2892364-59-7
-
Formula Weight527.56
-
Molecular FormulaC23H30FN3O8S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(C)(=O)(=O)O.O=C1C=2C3=C(C(=C(F)C2)N4CCC(OC([C@H](C)N)=O)CC4)CC[C@@H](C)N3C=C1C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Chloroquinoxaline su...
Chloroquinoxaline sulfonamide (Chloroquinoxaline) is a topoisomerase II alpha/beta toxin with antitumor activity and immunosuppressive properties that inhibits the proliferation of B16 melanoma cells in mice, and can be used to study metastatic colorectal cancer.
-
SN-38
LE-SN38 is NeoPharm’s NeoLipid liposomal formulation of SN-38, the active metabolite of irinotecan (Camptosar), a chemotherapeutic pro-drug approved for the treatment of advanced colorectal Y.
-
N-Acetyl-D-Glucosami...
N-acetyl-D-Glucosamine (GlcNAc) is a monosaccharide derivative of glucose. It is released by the action of O-GlcNAcase, in mammalian systems from proteins that have been post-translationally modified with O-GlcNAc.
